Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: transfer from osh for necrotizing pancreatitis major surgical or invasive procedure: none history of present illness: 53f with a history of pancreas divisum and recurrent pancreatitis transferred from hospital with acute pancreatitis. last night around 6pm, the patient reports she had acute onset of nausea, non-bilious vomiting, diarrhea, and abdominal pain. the emesis and diarrhea were non-bloody. she has had 6 episodes of vomiting and 4 episodes of diarrhea since last night. she has not eaten anything since yesterday evening. she states that these symptoms felt typical of her prior episodes of pancreatitis and that she attempted to take po dilaudid at home. her abdominal pain is diffuse and constant; it does not radiate. she rates the pain an . her vomiting and pain persisted, and she then presented to the hospital ed last night. . at the osh this morning, her vital signs were 97.8 110 136/99 18 96% on ra. an ekg showed sinus tachycardia. her wbc was 21, hct rose from 41 to 49.8. lipase was 1400, amylase 1096, ldh 308, glc 261, transaminases wnl. she had a contrast abd ct that was read as: diffusely enlarged head and body of pancreas with demonstration of extensive diffuse peripancreatic fat stranding, edema, and free fluid, consistent w/ acute pancreatitis. portions of the pancreatic head, body, and proximal tail fail to enhance, consistent with necrotizing pancreatitis. ascites is present. she was treated with ivf, pain control with dilaudid, and imipenem 500 mg q8h. the decision was made to transfer the patient to . . upon arrival to the floor, vitals were 97.0 113 118/80 17 91% on ra, 96% on 2l. she was dry appearing on exam and in mild distress due to pain. initial labs were notable for wbc 26.4, hct 47.7, glc 233, normal ast ,ld 415, and lipase of ; calcium 8.3. past medical history: - pancreas divisum - htn - recurrent pancreatitis x 6; most recent ~1 year ago - osteoporosis - s/p ercp with stent on ; removed - s/p tubal ligation social history: -lives in , ma with her husband - works as a maid with maids - tobacco: no - etoh: no - illicits: no family history: - mother: died at 76 from mi, also htn, dm - father: htn, died at 57 from perforated ulcer - 3 healthy children physical exam: vs: 97 113 118/80 17 91% on ra; 96% on 2l gen: lying in hospital bed with towel over forehead, states she is in pain; alert and oriented x 3 heent: dry mucus membranes, perrl, eomi, jvp 5 cm, neck is supple, no cervical, supraclavicular, or axillary lad cv: hyperdynamic precordium, tachycardic, regular; systolic ejection murmur heard best at 2nd left intercostal space pulm: ctab abd: normoactive bs, soft, diffusely mildly ttp, no masses or hsm, no stigmata of chronic liver disease limbs: no le edema, no tremors or asterixis, no clubbing skin: no rashes or skin breakdown neuro: cnii-xii nonfocal, strength 5/5 of the upper and lower extremities, reflexes 2+ of the upper and lower extremities, toes down bilaterally on discharge: vs: 98.3, 88, 116/78, 18, 98% ra gen: nad, mildly depressed heent: nc/at, perrl, eomi, neck supple, mucus membranes moist cv: rrr, no m/r/g lungs: diminished b/l abd: soft, nd/nt, normoactive bs x 4 extr: warm, +pp, no c/c/e pertinent results: 11:22pm glucose-233* urea n-28* creat-1.0 sodium-136 potassium-5.4* chloride-103 total co2-20* anion gap-18 11:22pm estgfr-using this 11:22pm alt(sgpt)-22 ast(sgot)-31 ld(ldh)-415* alk phos-59 tot bili-1.2 11:22pm lipase-* 11:22pm albumin-4.4 calcium-8.3* phosphate-2.5* magnesium-1.6 11:22pm wbc-26.4*# rbc-5.28 hgb-16.4*# hct-47.7# mcv-91 mch-31.1 mchc-34.4 rdw-13.0 11:22pm plt smr-normal plt count-235 11:22pm pt-13.4 ptt-24.4 inr(pt)-1.1 05:19am blood wbc-13.1* rbc-3.51* hgb-10.9* hct-31.2* mcv-89 mch-31.2 mchc-35.0 rdw-13.2 plt ct-132* 05:19am blood glucose-229* urean-15 creat-0.4 na-138 k-4.0 cl-106 hco3-27 angap-9 05:19am blood alt-12 ast-20 alkphos-58 amylase-193* totbili-2.2* 06:00am blood caltibc-207* ferritn-863* trf-159* 05:33am blood wbc-35.7*# rbc-3.49* hgb-10.6* hct-30.4* mcv-87 mch-30.4 mchc-34.9 rdw-13.5 plt ct-507* 05:33am blood glucose-277* urean-19 creat-0.4 na-130* k-4.4 cl-96 hco3-24 angap-14 05:33am blood alt-17 ast-21 alkphos-116* amylase-444* totbili-0.6 05:41am blood wbc-15.8* rbc-2.81* hgb-8.5* hct-25.4* mcv-90 mch-30.2 mchc-33.4 rdw-14.1 plt ct-431 05:41am blood glucose-134* urean-18 creat-0.3* na-135 k-4.6 cl-105 hco3-22 angap-13 05:41am blood amylase-175* 05:41am blood calcium-8.1* phos-2.6* mg-1.8 06:07am blood caltibc-215* ferritn-681* trf-165* microbiology: 3:02 am urine source: cvs. **final report ** urine culture (final ): no growth. 4:24 am blood culture source: venipuncture. **final report ** blood culture, routine (final ): no growth. 9:28 am stool consistency: not applicable source: stool. **final report ** clostridium difficile toxin a & b test (final ): feces negative for c.difficile toxin a & b by eia. (reference range-negative). 5:57 pm stool consistency: not applicable source: stool. **final report ** clostridium difficile toxin a & b test (final ): reported by phone to @ 0539 on . clostridium difficile. feces positive for c. difficile toxin by eia. (reference range-negative). a positive result in a recently treated patient is of uncertain significance unless the patient is currently symptomatic (relapse). radiology: chest port: findings: no previous images. there are low lung volumes. atelectatic changes are seen at both bases. in the appropriate clinical setting, the possibility of supervening pneumonia could be considered. ct abd: impression: 1. extensive peripancreatic fat stranding. significant pancreatic fluid collections appear more organized when compared to study, without evidence of a pseudocyst formation. 2. a 9-mm saccular focus of enhancement near splenic artery, most likely represents a pseudoaneurysm. portal vein, smv and splenic vein appear patent. 3. interval resolution of ascites. chest cta: impression: no evidence of pulmonary embolism. new small bibasal pleural effusions and atelectasis. ekg: sinus tachycardia. possible prior septal myocardial infarction, age undetermined. compared to the previous tracing of the findings are similar. brief hospital course: 53 y/o female with recurrent pancreatitis pancreas divisum, transferred from hospital with acute pancreatitis and report from osh of necrotizing pancreatitis. patient was admitted on general surgery service for evaluation and treatments. patient's lipase was , and amylase - 338 on admission. . pancreatitis: thought to be the patient's known pancreas divisum. on transfer from osh, the patient showed evidence of intravascular hemoconcentration and met initial criteria. her cbc, lipase, chemistry inc. calcium, liver function tests, blood and urine cultures were followed. she received aggressive iv fluid resuscitation. her nausea was controlled with zofran and her pain with q3 dilaudid. on picc line was placed and nutrition consult was called for tpn recommendations. patient was started on tpn on . on patient was started on sips of clears, and her diet was advanced to clears on . later on , patient complained increase abdominal pain, and she was changed back to sips only, and later she was made npo. on patient diet was advanced to sips, and on - to clear liquids. patient tolerated clears well and on her diet was advanced to full liquids. on , patient's diet was advanced to regular. patient was able to tolerate only small amount of regular food, her abdominal pain increased dramatically, patient was made npo. on , patient diet advanced to clears, and later changed back to npo increased abdominal pain. on patient underwent abdominal ct scan, which demonstrated significant pancreatic fluid collections without evidence of a pseudocyst formation. patient's diet was advanced to sips of clears on , and advanced to clears on . patient was continued on tpn throughout hospitalization, her tpn was cycled prior discharge. patient was discharged on continue tpn as outpatient, she will follow up with dr. . patient will have an abdominal ct scan prior her follow up appointment. on discharge patient's lipase was 193, and amylase 175. . pain control: the patient received iv dilaudid 2-4 mg q3h on admission for pain control. when her pain improved, her dose was decreased to 0.5-1.0 mg with good effect. with good effect and adequate pain control. patient was required breakthrough dilaudid for spikes of pain. when tolerating oral intake, the patient was transitioned to oral pain medications. . cv/htn: on admission patient had sinus tachycardia and she was placed on telemetry to monitor her heart rate. after aggressive fluid resuscitation, patient heart rate converted to regular. patient continue to have episodes of sinus tachycardia, especially with increased pain or anxiety. patient takes on 15 mg of lisinopril to control her htn at home. while in hospital, she was found to have bp 180s-100s, and she was started on iv metoprolol with minimal effect. her bp continue to be high, she was started on iv hydralazine prn for sbp > 160. eventually, patient's bp became well controlled with this regiment. when tolerated po medication, patient was started on po metoprolol 50 mg , and her bp remained wnl. patient recommended to follow up with pcp after discharge to continue monitor her bp. . pulmonary: chest xray revealed bilateral atelectasis on admission. good pulmonary toilet, early ambulation and incentive spirrometry were encouraged throughout hospitalization. on patient developed rapid onset of the pleuritic chest pain and tachypnea, patient underwent chest cta which showed no evidence of pulmonary embolism. chest pain resolved spontaneously. patient remained stable from pulmonary stand point. . gu: patient's intake and output were closely monitored, and iv fluid was adjusted when necessary. electrolytes were routinely followed, and repleted when necessary. . leukocytosis/c-diff: on admission, patient's wbc was found to be 26.4. urine and blood cultures were sent for microbiology evaluation, and they were negative. patient was afebrile during hospitalization. wbc was tranding down until patient tried regular diet and her abdominal pain increased. patient's wbc spiked up to 25.7 on and stool was sent for c-diff. stool result was negative on . on patient's wbc went up to 35.7, patient remained afebrile. stool was sent for c-diff, and at this time was positive. patient was started on ciprofloxacin po x 14 days total. . hyperglycemia: patient doesn't have a history of diabetes, reports been hyperglycemic during acute pancreatitis in the past. patient was started on tpn and since that patient blood sugar increased to 250-300. insulin was increased in tpn, and patient was started insulin sliding scale. it was noticed that, when patient's abdominal pain is better her blood sugar is better as well. prior discharge insulin teaching was initiated and patient demonstrated good progress. patient will be discharge on tpn, she will continue to use insulin sliding scale at home. patient's lab will be followed weekly by team. patient instructed to contact her pcp or surgery team if she will have any questions regarding her insulin/blood sugar level. patient educated about hypo/hyper glycemia signs and symptoms . hematology: the patient's complete blood count was examined routinely; no transfusions were required. . prophylaxis: the patient received subcutaneous heparin and venodyne boots were used during this stay; was encouraged to get up and ambulate as early as possible. at the time of discharge, the patient was doing well, afebrile with stable vital signs. the patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. the patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. medications on admission: lisinopril 15', fosamax qmonth discharge medications: 1. lisinopril 20 mg tablet sig: one (1) tablet po daily (daily). 2. hydromorphone 2 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. disp:*120 tablet(s)* refills:*0* 3. acetaminophen 325 mg tablet sig: two (2) tablet po q4h (every 4 hours) as needed for pain. 4. metoprolol tartrate 50 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 5. insulin regular human 100 unit/ml solution sig: 6-20 units injection as directed. disp:*2 vial* refills:*2* 6. insulin syringe-needle u-100 ml 29 x5/16 syringe sig: one (1) syringe miscellaneous as directed. disp:*1 box* refills:*2* 7. alcohol prep swabs pads, medicated sig: one (1) pad topical as directed. disp:*1 box* refills:*2* 8. famotidine 20 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 9. heparin flush (10 units/ml) 2 ml iv prn line flush picc, heparin dependent: flush with 10ml normal saline followed by heparin as above daily and prn per lumen. 10. flagyl 500 mg tablet sig: one (1) tablet po three times a day for 12 days. disp:*36 tablet(s)* refills:*0* discharge disposition: home with service facility: home solutions infusion therapy discharge diagnosis: 1. acute pancreatitis 2. pancreas divisum 3. hyperglycemia discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - independent. discharge instructions: please resume all regular home medications , unless specifically advised not to take a particular medication. also, please take any new medications as prescribed. please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. avoid lifting weights greater than lbs until you follow-up with your surgeon, who will instruct you further regarding activity restrictions. avoid driving or operating heavy machinery while taking pain medications. please follow-up with your surgeon and primary care provider (pcp) as advised. please call your doctor or nurse practitioner if you experience the following: *you experience new chest pain, pressure, squeezing or tightness. *new or worsening cough, shortness of breath, or wheeze. *if you are vomiting and cannot keep down fluids or your medications. *you are getting dehydrated due to continued vomiting, diarrhea, or other reasons. signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *you see blood or dark/black material when you vomit or have a bowel movement. *you experience burning when you urinate, have blood in your urine, or experience a discharge. *your pain is not improving within 8-12 hours or is not gone within 24 hours. call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *you have shaking chills, or fever greater than 101.5 degrees fahrenheit or 38 degrees celsius. *any change in your symptoms, or any new symptoms that concern you picc line: *please monitor the site regularly, and your md, nurse practitioner, or nurse if you notice redness, swelling, tenderness or pain, drainage or bleeding at the insertion site. * your md to the emergency room immediately if the picc line tubing becomes damaged or punctured, or if the line is pulled out partially or completely. do not use the picc line in these circumstances.please keep the dressing clean and dry. contact your nurse if the dressing comes undone or is significantly soiled for further instructions. followup instructions: provider: scan phone: date/time: 10:45 . provider: , md phone: date/time: 11:30 3, . please follow up with dr. (pcp) regarding you blood pressure control or if you have any questions about insulin sliding scale procedure: venous catheterization, not elsewhere classified parenteral infusion of concentrated nutritional substances diagnoses: acidosis unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pulmonary collapse other specified cardiac dysrhythmias long-term (current) use of insulin osteoporosis, unspecified intestinal infection due to clostridium difficile other ascites chronic pancreatitis acute pancreatitis other specified diseases of pancreas 

Answer: The patient is high likely exposed to